Pharvaris (PHVS) Share-based Compensation (2020 - 2026)

Pharvaris (PHVS) posted Share-based Compensation of $5.7 million for Q1 2026, up 8.56% on a QoQ basis from $5.3 million in Q4 2025, and up 32.07% year-over-year from $4.3 million in Q1 2025.

Pharvaris (PHVS) Share-based Compensation (2020 - 2026) Analysis & Trends

Pharvaris' Share-based Compensation history runs 7 years deep, the most recent figure standing at $5.7 million for Q1 2026.

  • Quarterly Share-based Compensation rose 32.07% year-over-year to $5.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.0 million (up 19.05% YoY) and the FY2025 annual result came in at $21.5 million, up 22.69% from the prior year.
  • Share-based Compensation was $5.7 million for Q1 2026 at Pharvaris, up from $5.3 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $5771.1 billion in Q2 2023 and bottomed at -$5769.3 billion in Q3 2023.
  • A 5-year average of $108.1 million and a median of $4.2 million in 2024 frame the typical range for Share-based Compensation.
  • Peak annual rise in Share-based Compensation reached 172087079.47% in 2023, while the deepest fall reached 187987220.43% in 2023.
  • Pharvaris' Share-based Compensation stood at $3.3 million in 2022, then fell by 18.73% to $2.7 million in 2023, then soared by 93.92% to $5.2 million in 2024, then climbed by 2.16% to $5.3 million in 2025, then grew by 8.56% to $5.7 million in 2026.
  • Business Quant data shows PHVS's Share-based Compensation at $5.7 million in Q1 2026, $5.3 million in Q4 2025, and $5.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Pharvaris 2.17 Bn 1.88 Bn - 5.73 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.73 Mn
Mar 31, 2026 5.73 Mn
Dec 31, 2025 5.28 Mn
Dec 31, 2025 5.28 Mn
Sep 30, 2025 5.71 Mn
Sep 30, 2025 5.71 Mn
Jun 30, 2025 6.22 Mn
Jun 30, 2025 6.22 Mn
Mar 31, 2025 4.34 Mn
Mar 31, 2025 4.34 Mn
Dec 31, 2024 5.17 Mn
Dec 31, 2024 5.17 Mn
Sep 30, 2024 5.58 Mn
Sep 30, 2024 5.58 Mn
Jun 30, 2024 4.19 Mn
Jun 30, 2024 4.19 Mn
Mar 31, 2024 2.61 Mn
Mar 31, 2024 2.61 Mn
Dec 31, 2023 2.67 Mn
Dec 31, 2023 2.67 Mn